Keilholz, U., Scheibenbogen, C., Möhler, T., Brossart, P., Maclachlan, D., Geueke, A., . . . Hunstein, W. (1995). Addition of dacarbazine or cisplatin to interferon-α/interleukin-2 in metastatic melanoma: Toxicity and immunological effects. Melanoma research, 5(4), . https://doi.org/10.1097/00008390-199508000-00013
Chicago Style (17th ed.) CitationKeilholz, Ulrich, Carmen Scheibenbogen, Thomas Möhler, Peter Brossart, David Maclachlan, A.-M Geueke, Anita Jochim, and Werner Hunstein. "Addition of Dacarbazine or Cisplatin to Interferon-α/interleukin-2 in Metastatic Melanoma: Toxicity and Immunological Effects." Melanoma Research 5, no. 4 (1995). https://doi.org/10.1097/00008390-199508000-00013.
MLA (9th ed.) CitationKeilholz, Ulrich, et al. "Addition of Dacarbazine or Cisplatin to Interferon-α/interleukin-2 in Metastatic Melanoma: Toxicity and Immunological Effects." Melanoma Research, vol. 5, no. 4, 1995, https://doi.org/10.1097/00008390-199508000-00013.